| 1 |
Pranita Kerber |
IBM |
29 |
| 2 |
Bruce M. Fleischer |
IBM |
11 |
| 3 |
Srikanth Srinivasan |
Intel |
8 |
| 3 |
Andrzej Kochut |
IBM |
8 |
| #5 |
Daniel M. Bikel |
Google |
6 |
| #6 |
Antonio D. Corcoles Gonzalez |
IBM |
4 |
| #6 |
Lakshmi N. Reddy |
IBM |
4 |
| #8 |
Sarunya Bangsaruntip |
IBM |
3 |
| #8 |
Alla Segal |
IBM |
3 |
| #8 |
Gordon Kessler |
Ai Cure Technologies |
3 |
| #8 |
Eric R. Pohl |
Momentive Performance Materials Gmbh |
3 |
| #8 |
Karthik V. Swaminathan |
IBM |
3 |
| #13 |
Hoi-Cheong Steve Sun |
Ascensia Diabetes Care Holdings Ag |
2 |
| #13 |
Richard A. Wachnik |
IBM |
2 |
| #15 |
Marcel-Catalin Rosu |
IBM |
1 |
| #15 |
John J. Ritsko |
IBM |
1 |
| #15 |
Scott B. Meyer |
— |
1 |
| #15 |
Bachir Dirahoui |
IBM |
1 |
| #15 |
Cheng Wu |
IBM |
1 |
| #15 |
Ferdinand E. Orbeta |
Trine Access Technology |
1 |
| #15 |
Claudia Reisz |
Dstillery |
1 |
| #15 |
Arpan P. Mohorowala |
Globalfoundries |
1 |
| #15 |
Pavlos M. Vranas |
IBM |
1 |
| #15 |
Haifeng Qian |
IBM |
1 |
| #15 |
Shahriar Pooyan |
Rutgers, The State University Of New Jersey |
1 |
| #15 |
Michael J. Engel |
Akzo Nobel N.V. |
1 |
| #15 |
Christopher Harrison |
AT&T |
1 |
| #15 |
Shurong Tian |
IBM |
1 |
| #15 |
Andreas Kerber |
Globalfoundries |
1 |
| #15 |
Joel C. Reinhardt |
Regeneron Pharmaceuticals |
1 |
| #15 |
Ronald Perez |
IBM |
1 |
| #15 |
Dennis F. Manzer |
IBM |
1 |
| #15 |
Norman Haas |
IBM |
1 |
| #15 |
Thomas Coleman |
Araim Pharmaceuticals |
1 |
| #15 |
Stuart Marcus |
Dusa Pharmaceuticals |
1 |